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The underlying frameworks of natural product
classes with multiple biological activities can
be regarded as biologically selected and preva-
lidated starting points in vast chemical struc-
ture space in the development of compound
collections for chemical biology and medicinal
chemistry research. For the synthesis of natural
product-derived and -inspired compound col-
lections, the development of enantioselective
transformations in a format amenable to library
synthesis, e.g., on the solid support, is a major
and largely unexplored goal. We report on the
enantioselective solid-phase synthesis of a
natural product-inspired a,b-unsaturated d-lac-
tone collection and its investigation in cell-
based screens monitoring cell cycle progres-
sion and viral entry into cells. The screens
identified modulators of both biological pro-
cesses at a high hit rate. The screen for inhibi-
tion of viral entry opens up avenues of research
for the identification of compounds with anti-
viral activity.
INTRODUCTION
The identification of biologically active organic com-
pounds is of utmost importance both for basic research
and drug development. Besides the classical approach
of identifying compounds by in vitro screens, i.e., by bind-
ing to an isolated protein, high-content cell-based screens
have recently proven to be a powerful complementary ap-
proach [1–4]. Such a chemical-biological search strategy
provides the advantage of selecting compounds thatChemistry & Biology 14,can act at multiple steps along a given biochemical path-
way, monitored in a cellular context.
For this chemical-biological approach, compound clas-
ses need to be found that can be regarded as biologically
prevalidated in vast chemical structure space, and effi-
cient methods for their syntheses in a library format need
to be devised. The search may be particularly yielding
if links from such compound classes to the biological
phenomena monitored in the respective cellular screens
already exist (see below) [5, 6].
We have proposed to employ the frameworks of natural
product classes as evolutionary selected and biologically
prevalidated starting points in structural space for com-
pound collection development [7–11] and developed
a tree-like classification of the natural product frameworks
identified in nature so far [11]. The biology-oriented syn-
thesis (BIOS) of compound collections derived from these
natural product frameworks provides a promising strategy
in the search of new biologically active agents [12] and can
be efficiently carried out on polymer-bound substrates,
as they allow rapid diversification without intermediate
purification steps.
Natural product-derived and -inspired compound col-
lections have been synthesized on the solid support in a
number of cases [13–24]. However, in order to meet
the stereochemical demands of natural product frame-
works, the use of enantioselective transformations on the
solid phase presents a highly attractive though rarely
addressed approach.
Here, we report on the enantioselective solid-phase
synthesis of a natural product-inspired a,b-unsaturated
d-lactone collection and its investigation in cell-based
screens monitoring cell cycle progression and viral entry
into cells. This a,b-unsaturated d-lactone motif belongs
to the most frequently occurring scaffolds in nature [11]
and is the characteristic underlying structural element of
antiproliferative agents, immunosuppressants, and inhibi-
tors for different enzymes, in particular protein phospha-
tases (see Figure 1) [25–30].443–451, April 2007 ª2007 Elsevier Ltd All rights reserved 443
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Biology-Oriented Synthesis of DehydrolactonesFigure 1. Structures of Natural Products
Embodying the a,b-Unsaturated d-Lac-
tone Core Structure and Retrosynthetic
Analysis for the Synthesis of a,b-Unsatu-
rated d-Lactones on the Solid PhaseRESULTS AND DISCUSSION
For the development of an asymmetric solid-phase syn-
thesis of a,b-unsaturated d-lactones we employed the
enantioselective oxa Diels-Alder reaction between alde-
hydes and electron-rich 1-alkoxydienes [31–35] immobi-
lized on the polymeric carrier as key stereodifferentiating
transformation [36–40]. 1-Alkoxydienes were synthesized
on the solid support and subjected to enantioselective cy-
cloaddition with ethyl glyoxylate as the reactive heterodie-
nophile (see Figure 1 for the retrosynthetic rationale). Sub-
sequent derivatization of the ester followed by oxidation
of the acetal cycloadduct to the lactone was supposed
to give rise to a compound collection (see below) [13–26].
To this end, bromo-Wang polystyrene resin, 1 (loading
1.7 mmol$g1), was treated with the sodium salt of
3-hydroxyacrolein to yield polymer-bound a,b-unsatu-
rated aldehyde, 2 (loading 1.0–1.6 mmol$g1, determined
by titration with dinitrophenylhydrazine [17]), which was
then transformed into immobilized dienes 3a/b by means
of a Wittig reaction (Figure 2). Next, the enantioselective
hetero Diels-Alder reaction with ethyl glyoxylate was
explored. After substantial experimentation, it was found
that it proceeded with 90%–95% ee in the presence of444 Chemistry & Biology 14, 443–451, April 2007 ª2007 Elsevie50 mol% Ti-(R)-BINOL complex 6 [31–33]. Methyl-
substituted diene 3b yielded only the syn isomer [41–44],
with (R) configuration at C-6. The syn configuration was
determined by comparison of the 1H-NMR spectrum
with data given in the literature [41–44]. The absolute
and relative configurations of the cycloadducts were de-
termined after release of the lactones from the resin and
comparison of their specific rotations and characteristic
NMR data with the corresponding values reported in the
literature. After cleavage from the resin, compound 5a
was identical to the oxidation product of literature-known
(2R, 6S)-6-methoxy-3,6-dihydro-2H-pyran-2-carboxylic
acid ethyl ester (see [45]).
Release of the cycloadducts and oxidation to the lac-
tones 5was efficiently achieved in a single-step procedure
by treatment of polymer-bound acetals 4 with the Jones
reagent [46]. After flash chromatography, compounds 5
were isolated with >95% purity and in overall yields for
the four-step sequence of 40% (5a) and 15% (5b), i.e.,
with 80% and 62% average yield per step.
For the synthesis of a compound collection, the ethyl
ester was saponified on resin with LiOH [47] (Figure 2),
and the resulting immobilized acids 7 were treated with
different alkyl halides in the presence of cesium carbonater Ltd All rights reserved
Chemistry & Biology
Biology-Oriented Synthesis of Dehydrolactones[48, 49] to finally deliver esters 10 in ca. 50% (aliphatic ha-
lides) to ca. 80% (benzyl halides and a-halocarboxylic
acid esters) yield. Similarly, amides 11 were obtained in
yields of ca. 50% after activation of the carboxylic acids
with PyBOP (Figure 2). Notably, neither the nucleophilic
ester formation nor the activation in the course of the
amide synthesis affected the stereoisomer ratio initially
established during the cycloaddition. a,b-Unsaturated
d-lactones 10 and 11 were isolated with purities typically
>90% after flash chromatography or purification by pre-
parative reverse-phase HPLC on a C18 column. A selec-
tion of representative examples is shown in Table 1 (see
Table S1 in the Supplemental Data available with this
Figure 2. Solid-Phase Synthesis of the a,b-Unsaturated
d-Lactones
(a) Sodium-3-oxacrolein, DMF, rt, 18 hr, 65%–90%. (b) MePh3PBr or
EtPh3PBr, n-BuLi, THF, rt, 18 hr. (c) 50 mol% (Ti[(R)-BINOL][OiPr]2)
(6), 10 equiv. ethyl glyoxylate, CH2Cl2, 30C–0C, 6 hr. (d) CrO3,
H2SO4, acetone/water, rt, 5 hr. (e) 20 equiv. LiOH, THF/water, rt,
5 hr. (f) 10–20 equiv. R2-Br or R2-Cl, 10–20 equiv. Cs2CO3, 0–1 equiv.
NaI, DMF, rt, 24–144 hr. (g) 5 equiv. PyBOP, 10 equiv. DIEA, 5 equiv.
H2NR
2, DMF, rt, 2–5 hr. PyBOP, benzotriazole-1-yl-oxy-trispyrrolidino-
phosphonium hexafluorophosphate; DIEA, N,N-diisopropylethyl-
amine. (h) CrO3, H2SO4, acetone/water, rt, 5 hr. (i) 4 equiv. LiBH4,
THF, 0C to rt, 18 hr. (j) 4 equiv. IBX, THF/DMSO, rt, 20 hr. IBX,
o-iodoxybenzoic acid. (k) 5 equiv. R4PPh3Br, 4.7 equiv. n-BuLi, THF,
0C to rt, 18 hr. (l) 10–20 equiv. CrO3, H2SO4, acetone/water, rt, 5 hr.Chemistry & Biology 14, 4article online for a list of structures and yields of all
compounds synthesized).
In order to more closely approximate the structure of the
guiding natural products, ester 4a was converted into
immobilized aldehyde 12, which was then subjected to
a Wittig reaction with different phosphonium salts. Olefins
14 were finally released from the solid support by again
employing the Jones oxidation protocol. The double
bond next to the lactone ring resembles the core structure
of various naturally occurring a,b-unsaturated d-lactones
(Figure 1), and, in fact, goniothalamin (see Table 1) and
several related compounds (see the Supplemental Data)
were obtained by this solid-phase procedure.
By means of the sequence of syntheses detailed above,
a collection of 50 compounds was synthesized.
In order to test for biological activity, the synthesized
compound collection was subjected to the aforementioned
cell-based screens.
Pironetin (Figure 1) arrests cell cycle progression in M
phase and is a potent inhibitor of tubulin assembly [50–
52], indicating a possible link between this biological
process and a,b-unsaturated d-lactones.
Therefore, the synthesized compounds were subjected
to a phenotypic cell-based screen monitoring their influ-
ence on cell cycle progression. In this screen, BSC-1 cells
(from African green monkey) cultured in 384-well plates
were treated for 8 hr with 30 mM of the synthesized com-
pounds. This cell line was chosen due to its proven advan-
tage in assessing the influence of chemical compounds on
the cell cycle [53]. Treated cells were fixed with formalde-
hyde and stained for chromatin and the actin- and micro-
tubule cytoskeleton. Microscopic analysis revealed that
several of the investigated compounds influenced the mi-
crotubule cytoskeleton in dividing and/or nondividing
cells. Closer examination of the compound-induced phe-
notypes revealed that, for example, 10a/10 and 11a/1
induced the formation of bipolar spindles with a high fre-
quency of misaligned chromosomes (see Figure 3). The
pole-to-pole distance of spindles observed in cells treated
with 100 mM 10a/10 appeared to be greater than in
DMSO-treated cells (see Figure 3A), suggesting that these
compounds might affect proteins involved in regulating
spindle morphology. At this concentration, 10a/10 also af-
fected the actin cytoskeleton, as shown in Figure 3. While
10a/10 induced the formation of larger spindles, 11a/1
did not affect spindle length, but caused severe defects
in chromosome alignment (see Figure 3). Additionally,
11a/1-treated cells displayed a bent spindle phenotype
with curvy and disorganized microtubules, indicating that
11a/1, like 10a/10, might affect microtubule dynamics.
As evident from Figure 3, compound 11a/1, unlike
10a/10, did not affect the actin cytoskeleton. To confirm
that the observed cellular phenotypes were mediated by
10a/10 and 11a/1 rather than by possible decomposition
products cells were treated with benzyl alcohol and
alanine methyl ester, the products of eventual intracellular
esterase or peptidase cleavage. Intriguingly, these com-
pounds had no effect on either the actin- or microtubule
cytoskeleton, confirming that 10a/10 and 11a/1 account43–451, April 2007 ª2007 Elsevier Ltd All rights reserved 445
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Biology-Oriented Synthesis of DehydrolactonesTable 1. Selected a,b-Unsaturated d-Lactones
Obtained by Enantioselective Solid-Phase Synthesis
Entry Compound Structure
1 10a/1
2 10a/2
3 10a/3
4 10a/4
5 10a/5
6 10a/10
7 10a/12
8 10b/9
9 10b/21
10 11a/1
11 11b/1
12 11b/2446 Chemistry & Biology 14, 443–451, April 2007 ª2007 Elseviefor the observed cellular effects. Since both compounds
induced defects in microtubule morphology, in vitro as-
says were performed to analyze the effect of 10a/10 and
11a/1 on microtubule polymerization. To this end, tubulin
purified from pig brain was induced to polymerize in the
presence of GTP by incubating it at 30C in the presence
of 10a/10, 11a/1, DMSO as a solvent control, or the micro-
tubule poison nocodazole [54]. To obtain a quantitative
readout, we monitored microtubule polymerization by
measuring the turbidity of the reaction at 350 nm. As
shown in Figure S1, tubulin efficiently polymerized into mi-
crotubule polymers in the presence of DMSO, as evident
from the fact that the absorbance constantly increased
until it started to plateau about 12 min after the start of
the reaction. To confirm that microtubule polymer, but
not protein aggregates, account for the observed increase
in absorbance, reactions were cooled to 15C after 25 min
(black triangle in Figure S1) to induce microtubule depoly-
merization. As expected, the cold treatment rapidly in-
duced a decrease in absorption, confirming that the
turbidity was mediated by microtubule polymer. Both
10a/10 and 11a/1 had a reproducible inhibitory effect on
microtubule polymerization at a concentration of 80 mM
(see Figure S1, each compound was tested in duplicate).
Notably, 5b (Table S1) which is structurally related to
10a/10 and 11a/1 but did not affect the cytoskeleton in
cells, had no significant effect on microtubule polymeriza-
tion in vitro, indicating that there is a correlation between
the cellular phenotype and the inhibitory activity on micro-
tubule polymerization in vitro. At higher concentration,
both compounds were less efficient in inhibiting micro-
tubule polymerization (data not shown), indicating that
10a/10 and 11a/1 might not be soluble at high concentra-
tions. Therefore, the IC50 values of 10a/10 and 11a/1 on
microtubule polymerization could not be determined.
Compared to nocodazole, both compounds were less ef-
ficient in inhibiting microtubule polymerization in vitro (see
Figure S1), suggesting that the observed cellular effects of
10a/10 and 11a/1 upon the microtubule cytoskeleton
might not be exclusively mediated by their inhibitory effect
on microtubule polymerization. Further work will be re-
quired to address questions of potencies, selectivities,
and mode of mechanisms of the compounds 10a/10
and 11a/1. Since spindle-associated proteins and micro-
tubules are promising targets for chemical biology
Table 1. Continued
Entry Compound Structure
13 14/1
14 14/5r Ltd All rights reserved
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Biology-Oriented Synthesis of DehydrolactonesFigure 3. Results of the Assay for Influence on the Progression of the Cell Cycle
Immunofluorescent images of BSC-1 cells treated with compounds 10a/10, C10a/10 (benzyl alcohol), 11a/1, and C11a/1 (alanine methyl ester).
Chromatin-, actin-, and microtubule structures are shown individually and as an overlay colored in blue, red, and green, respectively.research and drug development [55], these studies might
open up new avenues of research in these areas of inves-
tigation.
The second cell-based screen exploits the property of
vesicular stomatitis virus (VSV) to hijack the endocytic
pathway to infect host cells. VSV enters via clathrin-medi-
ated endocytosis and is transported to early and late en-
dosomes (see Figures 4A and 4B). This assay has recently
been used to explore genome-wide the function of ki-
nases at various steps of the clathrin-mediated endocytic
route by RNA interference (RNAi); this assay was per-
formed in HeLa cells and uncovered an unexpected
complexity of regulation of protein, lipid, and carbohy-
drate phosphorylation in this biological process [56].
Given that the natural products based on a,b-unsaturated
d-lactones are also functionally related to protein phos-
phorylation (see above), and that kinases and phospha-
tases may have both activating and inactivating functions,
we probed the activity of the synthesized compounds by
using this cell-based assay validated for human kinases.
Infection of HeLa cells by a recombinant VSV-expressing
GFP (rVSP-GFP) in the presence of individual compounds
(30 mM) was monitored by imaging GFP expression in
96-well plates by using a fully automated confocal micro-
scope (Figure 4C).Chemistry & Biology 14,Four different fields per well were imaged for GFP and
DRAQ5 for staining of nuclei. From each field, the number
of infected cells (the GFP channel) out of total cells
(DRAQ5) was determined by using an automated image-
analysis algorithm. The average number of infected cells
in each well and, from these, the total average were calcu-
lated. By dividing the number of infected cells by the num-
ber of infected cells from negative control wells, the relative
VS infection index was calculated, as described [56]. The
relative cell number was obtained by dividing the number
of cells by the number of cells from negative control wells.
All data were collected in two independent experiments.
Positive hits were considered when the relative VSV
infection index was reduced or enhanced at least 3-fold
in the presence of the respective compound, as described
[56].
A total of eight a,b-unsaturated d-lactones reduced vi-
rus infectivity and the relative cell number at least 3-fold
(Figure 4D). An increase in virus infectivity was not
observed. Notably, four of these compounds (Figure 4D)
reduced virus infectivity but did not lower the relative cell
number below the threshold. Three compounds, namely,
10a/8, 10a/14, and 10b/10, did exclusively score in this
screen, indicating selectivity. Comparison of the struc-
tures of these two groups of compounds suggests that443–451, April 2007 ª2007 Elsevier Ltd All rights reserved 447
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Biology-Oriented Synthesis of DehydrolactonesFigure 4. rVSV-GFP Infectivity Assay
(A and B) Schematic illustration of the assay principle.
(C) Images acquired in the screen: (a) control, (b) 10a/10, (c) 10b/10, (d)
11a/2, and (e) 10a/14; note that the amide 11a/2 did not score in the
screen.
(D) Structures of the compounds identified as hits in the screen.448 Chemistry & Biology 14, 443–451, April 2007 ª2007 Elsevian aromatic residue in the side chain of the lactones may
be beneficial for the selective mode of action. Also,
amides were not active (also see Figure 4D).
In order to further investigate the specificity of the com-
pounds under physiological conditions, the selected pos-
itive hits were again compared with their potential cleav-
age products (i.e., alcohols). HeLa cells incubated with
esters and alcohols were infected by using VSV, and the
infection rate was determined (Figure 5). The results
clearly show that whereas all esters reduced VSV infectiv-
ity, their respective alcohols failed, indicating that the a,b-
unsaturated d-lactone moiety is essential for activity. Ad-
ditionally, the data show that an even shorter incubation
time (2 hr) is sufficient to protect cells from viral infection;
the active compounds are stable at least during this period
of time (see the Supplemental Data).
Finally, we found that the known apoptosis-inducing
compound staurosporine did not affect the number of
Figure 5. Comparison of Active Esters with the Correspon-
dent Alcohols
(A) Cell scoring in HeLa cells treated with active ester and correspond-
ing alcohols does not show any major difference from untreated cells,
indicating an absence of acute cytotoxicity during the experimental
window.
(B) VSV infectivity of cells is strongly reduced in HeLa cells treated with
the active esters, but it is not significantly changed in HeLa cells
treated with the alcohols. C., control substance (i.e., corresponding
alcohol); Unt., untreated; STS, staurosporine.
Error bars indicate the standard deviations for the measurements.er Ltd All rights reserved
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excluding the possibility that the effect of the active a,b-
unsaturated d-lactones is due to induction of cell death and
consequent impairment of basic physiological functions.
Several signaling pathways involving phosphorylation
events, particularly the cell growth TOR, the MAP kinase,
the Ca2+, and the actin turnover pathways, have been
shown to require or stimulate clathrin-mediated endocyto-
sis [56]. Interestingly, ablation of several of the kinases
identified in the kinome survey displayed strictly path-
way-specific effects on cell viability and proliferation.
Given the known connection between the phosphatase-
inhibiting activity of several of the guiding natural products
(see above) and the antagonizing effects of phosphatases
and kinases, it is conceivable that the compounds iden-
tified to specifically inhibit VSV infection (i.e., without
affecting cell number) may act upon a subset of protein
phosphatases and/or kinases acting on this endocytic
pathway. In this respect, the siRNA kinome-wide screen
[56] offers a number of suitable candidates.
These initial results demonstrate that the methodology
developed by us offers a new, to our knowledge, principle
for screening small molecules in the field of viral infection.
In particular, the combination of this screening method
with genome-wide RNAi screens should provide an effi-
cient means for identification of novel regulatory path-
ways, novel targets within these pathways, as well as
chemical modulators acting upon them.
In conclusion, we demonstrate that highly enantioselec-
tive oxa Diels-Alder reactions with solid-phase, bound di-
enes can successfully be carried out by employing a chiral
titanium catalyst. Elaboration of the cycloadducts into
a compound collection resembling naturally occurring
a,b-unsaturated d-lactones was successfully achieved.
This collection proved to yield new, to our knowledge,
modulators of cell cycle progression and viral entry into
cells at a high hit rate in cell-based assays and thereby
may open up new avenues of research. The natural prod-
uct-derived a,b-unsaturated d-lactone moiety was essen-
tial for the observed effects in all cases. We note that the
screen monitoring viral entry in general provides an
unprecedented opportunity for the identification of novel
classes of antiviral compounds.
SIGNIFICANCE
The use of small molecules for the study of biological
phenomena is of major interest to chemical biology
and medicinal chemistry research. For such en-
deavors, compound classes that can be regarded as
relevant to biology, that are amenable to compound
collection development, and that yield high hit rates
at a comparably small library size are required.
In order to develop compound collections that meet
these criteria, we propose to employ classes of natu-
ral products with prevalidated biological relevance
as starting points in structure space. The effort re-
quired for the synthesis of such compound collections
exceeds the set of transformations typically employedChemistry & Biology 14in combinatorial chemistry; in particular, enantiose-
lective transformations are needed. Here, we present
the development of enantioselective oxa Diels-Alder
reactions for the synthesis of natural product-inspired
compound collections in a format amenable to com-
pound library synthesis. Hetero Diels-Alder reactions
catalyzed by a chiral titanium complex were employed
to obtain a collection of 50 a,b-unsaturated d-lac-
tones, a structural motif present in various biologically
active natural products.
The resulting compoundcollectionwas subjected to
biological evaluation in phenotype-based screens and
yielded new, to our knowledge, modulators of cell cy-
cle progression and inhibitors of viral entry into cells.
EXPERIMENTAL PROCEDURES
A record of all experimental procedures and characterization of repre-
sentative compounds is given in the Supplemental Data.
General Procedure for Diene Formation on the Solid Support
The phosphonium salt (3 equiv.) was suspended in 10 ml dry THF, and
a solution of n-BuLi (1.6 M in hexane, 2.9 equiv.) was slowly added. The
deep-red solution was added to the polymer-bound aldehyde (5 g,
5.84 mmol) in 20 ml dry THF. The mixture was shaken for 12 hr at
room temperature. The resin was filtered, washed with 3:1 THF:H2O
(50 ml), THF (100 ml), DMF (50 ml), MeOH (30 ml), and CH2Cl2
(100 ml), and dried in vacuo. The completion of the reaction was
confirmed by monitoring the disappearance of the C=O band in the IR.
General Procedure for the Hetero Diels-Alder Reaction
on the Solid Support
(R)-BINOL (1.7 mmol, 1 equiv.) was dissolved in 7.5 ml dry CH2Cl2, and
a solution of Ti(OiPr)4 (0.85 mmol, 0.5 equiv.) in 2.5 ml dry CH2Cl2 was
added. The mixture was heated to reflux for 1 hr, then evaporated and
dried in vacuo for 1.5 hr. The catalyst dissolved in 10 ml dry CH2Cl2 was
added to the suspension of the polymer-bound diene (1 g, 1.7 mmol) in
10 ml dry CH2Cl2 that was cooled to 30C. Freshly distilled ethyl
glyoxylate (10 equiv.) was added in small amounts over the course of
3 hr at a constant temperature of 30C. The mixture was allowed
to warm up to 0C over the course of 2hr. The resin was filtered,
washed with CH2Cl2 (20 ml), DMF (20 ml), 1:1 DMF:H2O (25 ml),
DMF (25 ml), MeOH (20 ml), and CH2Cl2 (50 ml), and dried in vacuo.
After the cleavage of a small amount (100 mg), the loading resulted
in 0.4–0.1 mmol/g (30%–10%).
Cell Cycle Progression Screen
BSC-1 (African green monkey) cells were cultured in 384-well plates at
a density of about 1500 cells per well. Compounds dissolved in DMSO
were transferred by a robot-controlled pin array to a final concentration
of about 30 mM. BSC-1 cells treated for 8 hr with the synthesized com-
pounds or an equivalent volume of DMSO were fixed with 4% formal-
dehyde (80 mM PIPES [pH 6.8], 1 mM MgCl2, 1 mM EGTA, 0.1% Triton
X-100) and were stained for microtubules, actin, and chromatin with
FITC-labeled anti-tubulin antibodies (Sigma), TRITC-labeled Phalloidin
(Sigma), and Hoechst (Sigma), respectively. Images were acquired on
an automated microscope (Zeiss 200M) equipped with a 203 lens.
High-quality images were acquired on a Nikon T200 inverted fluores-
cence microscope and were deconvolved by using Applied Precision
software.
rVSV-GFP Infectivity Assay
HeLa cells (human cervix carcinoma cell line) were obtained from
DSMZ, Braunschweig and maintained in D-MEM medium (GIBCO-
BRL) without phenol red supplemented with 10% fetal calf serum, 443–451, April 2007 ª2007 Elsevier Ltd All rights reserved 449
Chemistry & Biology
Biology-Oriented Synthesis of Dehydrolactones(FCS), 2 mM L-glutamine, and 1% penicillin-streptomycin. The cell
number was determined with a CASY cell counter (Scha¨rfe System
GmBH, Reutlingen). The cells were incubated at 37C in 5% CO2
and were seeded by using the Multidrop 384 dispenser (Thermo). On
day 0, 4000 HeLa cells were plated in 80 ml complete medium in
96-well (3619, Corning) plates and were incubated at 37C and 5%
CO2 overnight. At day 1, compounds were added to the cells at a final
concentration of 30 mM and were incubated. After 18 hr, rVSV-GFP
was added to the cells. To assure specific pathway entry of the virus,
a multiplicity of infection (MOI) of 0.1 was used in the experiment. After
the infection period of 4 hr, 50 ml 16% formaldehyde in PBS was added,
and the cells were fixed for at least 20 min. Nuclei were stained with
DRAQ5, and samples were imaged.
To assess the effect of the ester’s potential cleavage products, HeLa
cells were incubated with both lactone esters and their corresponding
alcohols for 2 hr. After this time, cells were infected with VSV for 3 hr
(the time necessary to obtain expression of GFP). Cells were then fixed
and processed as described above. Samples were done in duplicate,
and the experiments were repeated twice. Results were calculated for
each experiment as the average of the duplicate and its standard de-
viation (intraexperiment variation). Finally, results of the two indepen-
dent experiments were compared as the average of the experiment
and its standard deviation (interexperiment variation).
In control samples, an average number of cells of 1000 were
detected. Images were acquired with a 103 lens and an automated
confocal microscope (OPERA, Evotec Technologies, Hamburg,
Germany).
Supplemental Data
Supplemental Data include descriptions of additional general reaction
procedures, a list of all synthesized compounds with the results of the
syntheses, data for characterization of representative examples for
a,b-unsaturated d-lactones, a description of the tubulin polymerization
assay, and the results of the viral entry screen and are available at
http://www.chembiol.com/cgi/content/full/14/4/443/DC1/.
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